Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 1, 1990
Increased lactate appearance and reduced clearance during hypoxia in dogsW C Stanley, C D Mazer, R A Neese, et al.
Metabolism: Clinical and Experimental|September 1, 1990
Myocardial metabolism during hypoxia: maintained lactate oxidation during increased glycolysisC D Mazer, W C Stanley, R F Hickey, et al.
Transfusion Medicine (Oxford, England)|April 11, 2008
The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy frameworkC J Moltzan, D A Anderson, J Callum, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 31, 2004
A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgeryD C H Cheng, C D Mazer, R Martineau, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|June 7, 2021
Advantages and limitations of various treatment chamber designs for reversible and irreversible electroporation in life sciencesElena Zand, Felix Schottroff, Elisabeth Steinacker, et al.
British Journal of Anaesthesia|June 19, 2016
Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapyN Rahe-Meyer, J H Levy, C D Mazer, et al.
Nature|May 24, 2008
Seismogenic lavas and explosive eruption forecastingY Lavallée, P G Meredith, D B Dingwell, et al.
Circulation|November 1, 1995
Intermittent warm blood cardioplegia. Warm Heart InvestigatorsS V Lichtenstein, C D Naylor, C M Feindel, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|May 7, 1999
Original articles: ease of wound closure as an endpoint of treatment efficacyM C Robson, S P Maggi, P D Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective seriesM J Rodrigues, J Peron, J-S Frénel, et al.
Pageof 7